Former analyses revealed an association between serum cytokine levels and a polymorphic variant upstream to the IL2 gene promoter (−330 T/G, rs2060762) assessed in MS and in neuroendocrine tumors [14, 34]. Here, IL2 is linked to myeloid sarcoma.